The estimated Net Worth of Christopher Fikry is at least $664 Тысяча dollars as of 26 November 2019. Mr. Fikry owns over 7,400 units of PPD Inc stock worth over $664,048 and over the last 5 years he sold PPD stock worth over $0. In addition, he makes $0 as Executive Vice President - Global Laboratory Services at PPD Inc.
Sign up
Mr. Fikry PPD stock SEC Form 4 insiders trading
Christopher has made over 1 trades of the PPD Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 7,400 units of PPD stock worth $199,800 on 26 November 2019.
The largest trade he's ever made was buying 7,400 units of PPD Inc stock on 26 November 2019 worth over $199,800. On average, Christopher trades about 1,480 units every 0 days since 2019. As of 26 November 2019 he still owns at least 14,045 units of PPD Inc stock.
You can see the complete history of Mr. Fikry stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Christopher Fikry biography
Christopher Fikry serves as Executive Vice President - Global Laboratory Services of the Company. Prior to joining the Company, Mr. Fikry served in various roles at Quest Diagnostics (DGX), from September 2012 to May 2017, including as vice president and general manager of oncology and companion diagnostics, and at Novartis AG (NUS) Vaccines and Diagnostics, from January 2007 to September 2012, including as director of strategic planning, head of the U.S. meningococcal and the U.S. influenza and travel vaccine franchises and vice president of U.S. marketing. He began his career in the healthcare practice of The Boston Consulting Group Inc.
How old is Christopher Fikry?
Christopher Fikry is 43, he's been the Executive Vice President - Global Laboratory Services of PPD Inc since 2017. There are 14 older and 4 younger executives at PPD Inc. The oldest executive at PPD Inc is Jeffrey Kindler, 64, who is the Independent Director.
What's Christopher Fikry's mailing address?
Christopher's mailing address filed with the SEC is C/O PPD, INC., 929 NORTH FRONT STREET, WILMINGTON, NC, 28401.
Insiders trading at PPD Inc
Over the last 21 years, insiders at PPD Inc have traded over $14,532,346,241 worth of PPD Inc stock and bought 130,455 units worth $3,520,800 . The most active insiders traders include Corporate Investors Viii, L..., Corporate Investors Vii, Lt... и Group Management L.L.C.Carl.... On average, PPD Inc executives and independent directors trade stock every 53 days with the average trade being worth of $124,899,671. The most recent stock trade was executed by Corporate Investors Viii, L... on 8 December 2021, trading 132,841,266 units of PPD stock currently worth $6,309,960,135.
What does PPD Inc do?
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Company's customers include pharmaceutical, biotechnology, medical device, academic and government organization s. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
What does PPD Inc's logo look like?
Complete history of Mr. Fikry stock trades at PPD Inc
PPD Inc executives and stock owners
PPD Inc executives and other stock owners filed with the SEC include:
-
David Simmons,
Chairman of the Board, Chief Executive Officer -
William Sharbaugh,
Chief Operating Officer -
Christopher Scully,
Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary -
Anshul Thakral,
Executive Vice President, Chief Commercial Officer -
B. Judd Hartman,
Executive Vice President, Chief Administrative Officer, General Counsel -
Jeffrey Kindler,
Independent Director -
Colin Hill,
Independent Director -
Maria Hilado,
Independent Director -
Tracy Krumme,
Vice President, Head of Investor Relations -
Stephen Wise,
Independent Director -
Allen Thorpe,
Independent Director -
P. Hunter Philbrick,
Independent Director -
Stephen Ensley,
Independent Director -
Joe Bress,
Independent Director -
Glen Donovan,
Chief Accounting Officer -
Roger Smith,
Senior Vice President and General Manager of AES -
Karen Kaucic,
Executive Vice President and President of Evidera, Chief Medical Officer -
David Johnston,
Executive Vice President - Global Clinical Development -
Christopher Fikry,
Executive Vice President - Global Laboratory Services -
Ronald Garrow,
Chief Human Resource Officer, Executive Vice President -
Group Inc.Carlyle Group Man...,
-
Group Management L.L.C.Carl...,
-
Jill Pellegrino,
SVP & General Manager of AES -
Peter Grunebaum,
Director -
Cecil Mark Brown,
Sr. VP & CEO -
Charlie Stephen Williamson,
Chief Financial Officer -
Kathleen Susan Pinson,
Vice President -
Randy Harp,
Chief Operating Officer -
Harland Cecil Stonecipher,
Founder, Chairman of the Board -
Martin H Belsky,
Director -
John W Hail,
Director -
Steven Riley Hague,
Director -
Paid Legal Services Inc Pre,
Director -
Judd Hartman,
See Remarks -
Thomas W Smith,
10% owner -
Corporate Investors Viii, L...,
-
Julia James,
EVP, General Counsel,Secretary